Search Within

Nikoletta Lendvai

Formats
  1. Meeting Abstract (71)
  2. Journal Article (33)
  3. Research Letter (2)
Groups
  1. Center for Hematologic Malignancies (106)
  2. Department of Medicine (106)
  3. Hematologic Malignancies, Division of (106)
  4. Myeloma (106)
  5. Hematologic Malignancies Research (77)
  6. Survivorship Research (74)

More Groups

People
  1. Alexander Lesokhin (71)
  2. Hani Hassoun (70)
  3. Heather Landau (68)
  4. Sergio Giralt (67)
  5. David Chung (61)
  6. Carl Landgren (53)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (7)
  4. 2019 (7)
  5. 2018 (14)
  6. 2017 (13)

More Years

Publications
  1. Blood (46)
  2. Biology of Blood and Marrow Transplantation (14)
  3. Leukemia and Lymphoma (9)
  4. Bone Marrow Transplantation (6)
  5. Journal of Clinical Oncology (6)
  6. Clinical Lymphoma, Myeloma and Leukemia (5)

More Publications

Publishers
  1. American Society of Hematology (47)
  2. Elsevier Inc. (21)
  3. Nature Publishing Group (10)
  4. Taylor & Francis Group (9)
  5. American Society of Clinical Oncology (6)
  6. Ferrata Storti Foundation (5)

More Publishers

Results (106)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 trial of carfilzomib + high dose melphalan conditioning regimen prior to autologous hematopoietic stem cell transplantation (AHSCT) for relapsed multiple myeloma
    Meeting Abstract

    Costa, L. J.; Landau, H.; Venkata, J. K.; Kang, Y.; Koehne, G.; Chung, D. J.; Lendvai, N.; Bentz, T.; Giralt, S.
    Blood (2013)

    Fulltext@MSK | Save
  • Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance
    Journal Article

    Zamarin, D.; Devlin, S. M.; Arcila, M. E.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Weltz, J.; Babu, D.; more...
    Leukemia (2013)

    Fulltext@MSK | Save
  • Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: Experience at Memorial Sloan Kettering Cancer Center
    Journal Article

    Pozotrigo, M.; Adel, N.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Riedel, E.; Chen, X.; Reich, L.; more...
    Bone Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with multiple myeloma undergoing autologous stem cell transplant
    Meeting Abstract

    Wood, K.; Giralt, S. A.; Koehne, G.; Chung, D.; Hassoun, H.; Lendvai, N.; Lesokhin, A.; Hoover, E.; Devlin, S.; Landau, H.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Patterns of relapse and progression in multiple myeloma patients after auto-SCT: Implications for patients' monitoring after transplantation
    Journal Article

    Zamarin, D.; Giralt, S.; Landau, H.; Lendvai, N.; Lesokhin, A.; Chung, D.; Koehne, G.; Chimento, D.; Devlin, S. M.; Riedel, E.; more...
    Bone Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Pilot study of MAGE-A3 protein vaccination and autologous stem cell transplantation (autoSCT) as consolidation therapy for multiple myeloma (MM)
    Meeting Abstract

    Cohen, A. D.; Lendvai, N.; Gnjatic, S.; Jungbluth, A. A.; Pan, L. S.; Bertolini, S. V.; Venhaus, R. R.; Fellague-Chebra, R.; Gruselle, O.; Cho, H. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Reactive polyclonal gammopathy associated with polyclonal plasmacytosis is common in patients with multiple myeloma receiving prolonged lenalidomide therapy: A retrospective study of 104 patients
    Meeting Abstract

    Zamarin, D.; Devlin, S.; Arcila, M.; Giralt, S. A.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Chimento, D.; Babu, D.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with multiple myeloma undergoing autologous stem cell transplant
    Meeting Abstract

    Wood, K.; Giralt, S. A.; Koehne, G.; Chung, D.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hoover, E.; Devlin, S.; Landau, H.
    Blood (2012)

    Fulltext@MSK | Save
  • Early changes in cytokines, chemokines and indices of bone metabolism in a phase 2 study of the bruton tyrosine kinase (Btk) inhibitor, ibrutinib (PCI-32765) in patients with relapsed or relapsed/refractory multiple myeloma (MM)
    Meeting Abstract

    Vij, R.; Chang, B. Y.; Berdeja, J. G.; Huff, C. A.; Lendvai, N.; Tai, Y. T.; Chang, S.; Moussa, D.; Buggy, J. J.; Elias, L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Phase II study of infusional carfilzomib in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Lendvai, N.; Landau, H.; Lesokhin, A.; Tsakos, I.; Koehne, G.; Chung, D.; Devlin, S.; Hassoun, H.; Giralt, S. A.
    Blood (2012)

    Fulltext@MSK | Save